ZNF20 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.96839997027121E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.01939999996858E-07 |
Normal-vs-Stage2 |
9.96190000490671E-08 |
Normal-vs-Stage3 |
6.96109836439973E-14 |
Normal-vs-Stage4 |
6.70750122111485E-11 |
Stage1-vs-Stage2 |
1.978220E-01 |
Stage1-vs-Stage3 |
5.11769999711476E-08 |
Stage1-vs-Stage4 |
2.401500E-03 |
Stage2-vs-Stage3 |
1.135630E-02 |
Stage2-vs-Stage4 |
2.647200E-01 |
Stage3-vs-Stage4 |
1.345170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.22819992959467E-10 |
Normal-vs-AfricanAmerican |
1.06780000397322E-08 |
Normal-vs-Asian |
3.030100E-02 |
Caucasian-vs-AfricanAmerican |
6.037200E-01 |
Caucasian-vs-Asian |
7.984600E-01 |
AfricanAmerican-vs-Asian |
6.636400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.33529964863044E-10 |
Normal-vs-Female |
4.92499996340712E-09 |
Male-vs-Female |
2.030800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.100900E-03 |
Normal-vs-Age(41-60Yrs) |
2.43859998860785E-09 |
Normal-vs-Age(61-80Yrs) |
1.17109988373443E-10 |
Normal-vs-Age(81-100Yrs) |
1.27860000365132E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.925600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.651610E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.307600E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.903360E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.107000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.168000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.630400E-02 |
Normal-vs-Grade 2 |
5.27500000013781E-07 |
Normal-vs-Grade 3 |
1.89369631087288E-11 |
Normal-vs-Grade 4 |
1.6278089987054E-12 |
Grade 1-vs-Grade 2 |
5.456200E-01 |
Grade 1-vs-Grade 3 |
1.551730E-02 |
Grade 1-vs-Grade 4 |
3.957300E-04 |
Grade 2-vs-Grade 3 |
2.15639999999739E-05 |
Grade 2-vs-Grade 4 |
4.77549999544635E-09 |
Grade 3-vs-Grade 4 |
3.412600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.54150000051001E-07 |
Normal-vs-ccB subtype |
9.18154441365004E-13 |
ccA subtype-vs-ccB subtype |
2.96369999985835E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.67190039590537E-10 |
Normal-vs-N1 |
5.166700E-04 |
N0-vs-N1 |
6.895400E-01 |
|
|